RxDoctor Payments Data
★ My doctorsLook up a doctor →

Howard Harris, MD

Orthopaedic Surgery · Bedford, TXNPI 1790762615

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (37.8%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. FX Shoulder Solutions, Inc accounts for 65.7% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $97,031, 3.9 times the $25,086 reported in 2019. Among orthopaedic surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$375,269in general payments, 2019–2025

Across 273 payments — averaging $1374.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • FX Shoulder Solutions, Inc$247K
  • Smith+Nephew$118K
  • Integrity Orthopaedics, Inc.$8K
  • Arthrex$2K
  • Pylant Medical$1K
  • Stryker$231
  • plus $199 from 4 others
$2,652,365in research payments, 2019–2025

Across 278 payments — averaging $9540.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$1.1M
  • Endo Pharmaceuticals Inc.$737K
  • FX Shoulder Solutions, Inc$711K
  • Pacira Therapeutics, Inc.$47K
  • Integrity Orthopaedics, Inc.$27K
$2,235,869in ownership & investment interests, 2019–2025

Across 6 payments — averaging $372,645 each. An ownership or investment interest held by the physician or an immediate family member.

  • Integrity Orthopaedics, Inc.$2.2M

What the payments were for

  • Royalty or licence$141,69238%
  • Consulting fees$68,94118%
  • Speaking & faculty fees$123,32533%
  • Travel & lodging$28,0427%
  • Food & beverage$10,2923%
  • Education$2,9771%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
FX Shoulder Solutions, Inc43$246,640
Smith+Nephew160$117,810
Integrity Orthopaedics, Inc.50$7,864
Arthrex4$1,517
Pylant Medical9$1,009
Stryker2$231
Avanos Medical1$63
Siemens Medical Solutions USA, Inc.2$52
Johnson & Johnson1$45
Boston Scientific1$39

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$375,269 in reported general payments places this provider in the 95th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas →

Medicare billing

Part B allowed, 2024
$520,417
Medicare patients
580
Services billed
5,694

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen204$2,181
Doxycycline Hyclate20$187
Ondansetron OdtOndansetron12$96
Tramadol Hcl19$60
Diazepam22$28
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$23

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Bedford

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →